Abstract
In previous and pioneer studies, we showed that, upon injection in the blood circulation, non-protein lipid nanoemulsions (LDE) with composition resembling low-density lipoprotein (LDL) have the ability to carry chemotherapeutic agents and concentrate them in malignant tumors or inflammation sites. By using LDE as vehicle, toxicity of those drugs was pronouncedly reduced without loss of a…